doripen vial inj
aristo - doripenem - inj - 500mg - vial
inarem vial inj
emcure - doripenem - inj - 1g - vial
inarem vial inj
emcure - doripenem - inj - 250mg - vial
inarem vial inj
emcure - doripenem - inj - 500mg - vial
prevymis
merck sharp & dohme (new zealand) limited - letermovir 240mg - concentrate for infusion - active: letermovir 240mg excipient: hydroxypropyl-beta-cyclodextrin sodium chloride sodium hydroxide water for injection - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).
prevymis
merck sharp & dohme (new zealand) limited - letermovir 480mg - concentrate for infusion - active: letermovir 480mg excipient: hydroxypropyl-beta-cyclodextrin sodium chloride sodium hydroxide water for injection - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).
prevymis
merck sharp & dohme (new zealand) limited - letermovir 240mg - film coated tablet - 240 mg - active: letermovir 240mg excipient: carnauba wax colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose opadry yellow 39k120004 povidone as povidone 25 purified water - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).
prevymis
merck sharp & dohme (new zealand) limited - letermovir 480mg - film coated tablet - 480 mg - active: letermovir 480mg excipient: carnauba wax colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose opadry pink 39k140009 povidone as povidone 25 purified water - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).
prevymis letermovir 480 mg/24 ml concentrated injection for infusion vial
merck sharp & dohme (australia) pty ltd - letermovir, quantity: 480 mg - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; hydroxypropylbetadex - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).
prevymis letermovir 240 mg/12 ml concentrated injection for infusion vial
merck sharp & dohme (australia) pty ltd - letermovir, quantity: 240 mg - injection, concentrated - excipient ingredients: water for injections; hydroxypropylbetadex; sodium chloride; sodium hydroxide - prevymis is indicated for the prophylaxis of cytomegalovirus (cmv) infection or disease in adult cmv-seropositive recipients [r+] of an allogeneic hematopoietic stem cell transplant (hsct).